Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$140.7m reported value -8.5% vs Q1 2025
38positions
66.1%in top 10
3 new 3 added 1 reduced 1 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $21.0m14.91% 14.91% UnchangedShares held: Q3 2024 5.5m, Q4 2024 5.5m, Q1 2025 5.5m, Q2 2025 5.5m
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 895,269 $12.6m8.98% 8.98% AddedShares held: Q3 2024 710.4k, Q4 2024 760.4k, Q1 2025 830.9k, Q2 2025 895.3k +64.4k +64,390 7.8%
3 ENTERA BIO LTD SHS ENTX ENTX 5,881,879 $11.2m7.95% 7.95% UnchangedShares held: Q3 2024 3.9m, Q4 2024 5.9m, Q1 2025 5.9m, Q2 2025 5.9m
4 SPDR GOLD TR GOLD SHS GLD GLD 32,000 $9.8m6.94% 6.94% UnchangedShares held: Q3 2024 32.0k, Q4 2024 32.0k, Q1 2025 32.0k, Q2 2025 32.0k
5 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,250,000 $8.2m5.79% 5.79% UnchangedShares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 1.2m
6 KINROSS GOLD CORP COM KGC KGC 440,000 $6.9m4.89% 4.89% UnchangedShares held: Q3 2024 440.0k, Q4 2024 440.0k, Q1 2025 440.0k, Q2 2025 440.0k
7 AGNICO EAGLE MINES LTD COM AEM AEM 55,500 $6.6m4.69% 4.69% UnchangedShares held: Q3 2024 55.5k, Q4 2024 55.5k, Q1 2025 55.5k, Q2 2025 55.5k
8 SANDSTORM GOLD LTD COM NEW SSL SSL 700,000 $6.6m4.68% 4.68% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 700.0k, Q2 2025 700.0k
9 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $5.3m3.78% 3.78% UnchangedShares held: Q3 2024 600.0k, Q4 2024 600.0k, Q1 2025 600.0k, Q2 2025 600.0k
10 ELICIO THERAPEUTICS INC COM ELTX ELTX 630,915 $4.9m3.46% 3.46% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 630.9k, Q2 2025 630.9k
11 SKEENA RES LTD NEW COM SKE SKE 295,400 $4.7m3.34% 3.34% ReducedShares held: Q3 2024 315.4k, Q4 2024 315.4k, Q1 2025 315.4k, Q2 2025 295.4k -20.0k -20,000 -6.3%
12 SEABRIDGE GOLD INC COM COM 317,003 $4.6m3.27% 3.27% UnchangedShares held: Q3 2024 317.0k, Q4 2024 317.0k, Q1 2025 317.0k, Q2 2025 317.0k
13 ALTIMMUNE INC COM NEW ALT ALT 1,121,524 $4.3m3.09% 3.09% UnchangedShares held: Q3 2024 1.1m, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
14 FRANCO NEV CORP COM FNV FNV 25,000 $4.1m2.91% 2.91% UnchangedShares held: Q3 2024 25.0k, Q4 2024 25.0k, Q1 2025 25.0k, Q2 2025 25.0k
15 MAG SILVER CORP COM MAG MAG 170,000 $3.6m2.55% 2.55% UnchangedShares held: Q3 2024 170.0k, Q4 2024 170.0k, Q1 2025 170.0k, Q2 2025 170.0k
16 NUVATION BIO INC COM CL A NUVB NUVB 1,025,000 $2.9m2.08% 2.08% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.0m, Q2 2025 1.0m
17 ISHARES SILVER TR ISHARES SLV SLV 80,000 $2.6m1.87% 1.87% UnchangedShares held: Q3 2024 80.0k, Q4 2024 80.0k, Q1 2025 80.0k, Q2 2025 80.0k
18 APPLIED THERAPEUTICS INC COM APLT APLT 7,799,687 $2.4m1.72% 1.72% UnchangedShares held: Q3 2024 5.6m, Q4 2024 5.8m, Q1 2025 7.8m, Q2 2025 7.8m
19 OCULAR THERAPEUTIX INC COM OCUL OCUL 600,400 $1.9m1.32% 1.32% UnchangedShares held: Q3 2024 600.4k, Q4 2024 600.4k, Q1 2025 600.4k, Q2 2025 600.4k
20 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.8m1.29% 1.29% UnchangedShares held: Q3 2024 10.0k, Q4 2024 10.0k, Q1 2025 10.0k, Q2 2025 10.0k
21 VISA INC COM CL A V V 4,850 $1.7m1.22% 1.22% UnchangedShares held: Q3 2024 4.8k, Q4 2024 4.8k, Q1 2025 4.8k, Q2 2025 4.8k
22 ROYAL GOLD INC COM RGLD RGLD 9,000 $1.6m1.14% 1.14% AddedShares held: Q3 2024 7.5k, Q4 2024 7.5k, Q1 2025 7.5k, Q2 2025 9.0k +1.4k +1,450 19.2%
23 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.4m1.03% 1.03% UnchangedShares held: Q3 2024 7.7k, Q4 2024 7.7k, Q1 2025 7.7k, Q2 2025 7.7k
24 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.4m0.96% 0.96% UnchangedShares held: Q3 2024 13.0k, Q4 2024 13.0k, Q1 2025 13.0k, Q2 2025 13.0k
25 ALAMOS GOLD INC NEW COM CL A AGI AGI 50,000 $1.3m0.94% 0.94% AddedShares held: Q3 2024 41.0k, Q4 2024 41.0k, Q1 2025 41.0k, Q2 2025 50.0k +9.0k +9,000 21.9%
26 WHEATON PRECIOUS METALS CORP COM WPM WPM 12,500 $1.1m0.80% 0.80% UnchangedShares held: Q3 2024 12.5k, Q4 2024 12.5k, Q1 2025 12.5k, Q2 2025 12.5k
27 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.1m0.77% 0.77% UnchangedShares held: Q3 2024 2.2k, Q4 2024 2.2k, Q1 2025 2.2k, Q2 2025 2.2k
28 COEUR MNG INC COM NEW CDE CDE 96,132 $851.7k0.61% 0.61% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 96.1k, Q2 2025 96.1k
29 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 260,470 $705.9k0.50% 0.50% UnchangedShares held: Q3 2024 260.5k, Q4 2024 260.5k, Q1 2025 260.5k, Q2 2025 260.5k
30 DIAGEO PLC SPON ADR NEW DEO DEO 6,750 $680.7k0.48% 0.48% UnchangedShares held: Q3 2024 6.8k, Q4 2024 6.8k, Q1 2025 6.8k, Q2 2025 6.8k
31 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 7,049 $666.7k0.47% 0.47% UnchangedShares held: Q3 2024 200.0k, Q4 2024 200.0k, Q1 2025 7.0k, Q2 2025 7.0k
32 NEW PAC METALS CORP COM NEWP NEWP 485,000 $649.9k0.46% 0.46% UnchangedShares held: Q3 2024 485.0k, Q4 2024 485.0k, Q1 2025 485.0k, Q2 2025 485.0k
33 HOOKIPA PHARMA INC COM COM 498,625 $625.8k0.44% 0.44% UnchangedShares held: Q3 2024 551.7k, Q4 2024 498.6k, Q1 2025 498.6k, Q2 2025 498.6k
34 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 62,689 $356.1k0.25% 0.25% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 62.7k
35 CENTERRA GOLD INC COM CGAU CGAU 1,227,863 $170.3k0.12% 0.12% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.2m
36 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 455,128 $169.8k0.12% 0.12% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 455.1k
37 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 100,000 $136.0k0.10% 0.10% UnchangedShares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 100.0k, Q2 2025 100.0k
38 Orgenesis, Inc. COM COM 50,623 $74.7k0.05% 0.05% UnchangedShares held: Q3 2024 63.5k, Q4 2024 50.6k, Q1 2025 50.6k, Q2 2025 50.6k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
EQUINOX GOLD CORP EQX EQX 550,811 $3.8m550.8k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08